Accès gratuit
Med Sci (Paris)
Volume 29, Numéro 12, Décembre 2013
Page(s) 1111 - 1116
Section M/S Revues
Publié en ligne 20 décembre 2013
  1. Stein DJ. Obsessive-compulsive disorder. Lancet 2002 ; 360 : 397–405. [CrossRef] [PubMed] [Google Scholar]
  2. Kessler RC, Berglund P, Demler O, et al. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National comorbidity survey replication. Arch Gen Psychiatry 2005 ; 62 : 593–602. [CrossRef] [PubMed] [Google Scholar]
  3. Abramowitz JS, Taylor S, McKay D. Obsessive-compulsive disorder. Lancet 2009 ; 374 : 491–499. [CrossRef] [PubMed] [Google Scholar]
  4. Taylor S. Early versus late onset obsessive-compulsive disorder: evidence for distinct subtypes. Clin Psychol Rev 2011 ; 31 : 1083–1100. [CrossRef] [PubMed] [Google Scholar]
  5. Katerberg H, Delucchi KL, Stewart SE, et al. Symptom dimensions in OCD: item-level factor analysis and heritability estimates. Behav Genet 2010 ; 40 : 505–517. [CrossRef] [PubMed] [Google Scholar]
  6. Weissman MM, Bland RC, Canino GJ, et al. The cross national epidemiology of obsessive compulsive disorder. The Cross national collaborative group. J Clin Psychiatry 1994 ; 55 : suppl 5–10. [Google Scholar]
  7. Pallanti S. Transcultural observations of obsessive-compulsive disorder. Am J Psychiatry 2008 ; 165 : 169–170. [CrossRef] [PubMed] [Google Scholar]
  8. Pauls DL. The genetics of obsessive-compulsive disorder: a review. Dialogues Clin Neurosci 2010 ; 12 : 149–163. [PubMed] [Google Scholar]
  9. Welch JM, Lu J, Rodriguiz RM, et al. Cortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice. Nature 2007 ; 448 : 894–900. [CrossRef] [PubMed] [Google Scholar]
  10. Nestadt G, Grados M, Samuels JF. Genetics of obsessive-compulsive disorder. Psychiatr Clin North Am 2010 ; 33 : 141–158. [CrossRef] [PubMed] [Google Scholar]
  11. Rotge JY, Aouizerate B, Tignol J, et al. The glutamate-based genetic immune hypothesis in obsessive-compulsive disorder. An integrative approach from genes to symptoms. Neuroscience 2010 ; 165 : 408–417. [CrossRef] [PubMed] [Google Scholar]
  12. De Leeuw AS, Westenberg HGM. Hypersensitivity of 5-HT2 receptors in OCD patients. J Psychiatr Res 2008 ; 42 : 894–901. [CrossRef] [PubMed] [Google Scholar]
  13. Chakrabarty K, Bhattacharyya S, Christopher R, et al. Glutamatergic dysfunction in OCD. Neuropsychopharmacology 2005 ; 30 : 1735–1740. [CrossRef] [PubMed] [Google Scholar]
  14. MacMaster FP, O’Neill J, Rosenberg DR. Brain imaging in pediatric obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry 2008 ; 47 : 1262–1272. [CrossRef] [PubMed] [Google Scholar]
  15. Haynes WIA, Mallet L. High-frequency stimulation of deep brain structures in obsessive-compulsive disorder: the search for a valid circuit. Eur J Neurosci 2010 ; 32 : 1118–1127. [CrossRef] [PubMed] [Google Scholar]
  16. Taj MJRJ, Viswanath B, Purushottam M, et al. DRD4 gene and obsessive compulsive disorder: Do symptom dimensions have specific genetic correlates? Prog Neuropsychopharmacol Biol Psychiatry 2013 ; 41 : 18–23. [CrossRef] [PubMed] [Google Scholar]
  17. Aouizerate B, Guehl D, Cuny E, et al. Pathophysiology of obsessive-compulsive disorder: a necessary link between phenomenology, neuropsychology, imagery and physiology. Prog Neurobiol 2004 ; 72 : 195–221. [CrossRef] [PubMed] [Google Scholar]
  18. Murphy TK, Storch EA, Lewin AB, et al. Clinical factors associated with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections. J Pediatr 2012 ; 160 : 314–319. [CrossRef] [PubMed] [Google Scholar]
  19. Brilot F, Merheb V, Ding A, et al. Antibody binding to neuronal surface in Sydenham chorea, but not in PANDAS or Tourette syndrome. Neurology 2011 ; 76 : 1508–1513. [CrossRef] [PubMed] [Google Scholar]
  20. Rotge JY, Guehl D, Dilharreguy B, et al. Meta-analysis of brain volume changes in obsessive-compulsive disorder. Biol Psychiatry 2009 ; 65 : 75–83. [CrossRef] [PubMed] [Google Scholar]
  21. Szeszko PR, Christian C, Macmaster F, et al. Gray matter structural alterations in psychotropic drug-naive pediatric obsessive-compulsive disorder: an optimized voxel-based morphometry study. Am J Psychiatry 2008 ; 165 : 1299–1307. [CrossRef] [PubMed] [Google Scholar]
  22. Whiteside SP, Port JD, Abramowitz JS. A meta-analysis of functional neuroimaging in obsessive-compulsive disorder. Psychiatry Res 2004 ; 132 : 69–79. [CrossRef] [PubMed] [Google Scholar]
  23. Rotge JY, Langbour N, Jaafari N, et al. Anatomical alterations and symptom-related functional activity in obsessive-compulsive disorder are correlated in the lateral orbitofrontal cortex. Biol Psychiatry 2010 ; 67 : e37–e38. [CrossRef] [PubMed] [Google Scholar]
  24. Zarei M, Mataix-Cols D, Heyman I, et al. Changes in gray matter volume and white matter microstructure in adolescents with obsessive-compulsive disorder. Biol Psychiatry 2011 ; 70 : 1083–1090. [CrossRef] [PubMed] [Google Scholar]
  25. Worbe Y, Baup N, Grabli D, et al. Behavioral and movement disorders induced by local inhibitory dysfunction in primate striatum. Cerebral Cortex 2009 ; 19 : 1844–1856. [CrossRef] [Google Scholar]
  26. Grabli D. Behavioural disorders induced by external globus pallidus dysfunction in primates. I. Behavioural study. Brain 2004 ; 127 : 2039–2054. [CrossRef] [PubMed] [Google Scholar]
  27. Karachi C, Grabli D, Baup N, et al. Dysfunction of the subthalamic nucleus induces behavioral and movement disorders in monkeys. Mov Disord 2009 ; 24 : 1183–1192. [CrossRef] [PubMed] [Google Scholar]
  28. Pallanti S, Quercioli L. Treatment-refractory obsessive-compulsive disorder: methodological issues, operational definitions and therapeutic lines. Prog Neuropsychopharmacol Biol Psychiatry 2006 ; 30 : 400–412. [CrossRef] [PubMed] [Google Scholar]
  29. Bloch MH, Landeros-Weisenberger A, Kelmendi B, et al. A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder. Mol Psychiatry 2006 ; 11 : 622–632. [CrossRef] [PubMed] [Google Scholar]
  30. Komossa K, Depping AM, Meyer M, et al. Second-generation antipsychotics for obsessive compulsive disorder. Cochrane Database Syst Rev 2010 : CD008141. [PubMed] [Google Scholar]
  31. Abramowitz JS. The psychological treatment of obsessive-compulsive disorder. Can J Psychiatry 2006 ; 51 : 407–416. [PubMed] [Google Scholar]
  32. Storch EA, Mariaskin A, Murphy TK. Psychotherapy for obsessive-compulsive disorder. Curr Psychiatry Rep 2009 ; 11 : 296–301. [CrossRef] [PubMed] [Google Scholar]
  33. Foa EB, Franklin ME, Moser J. Context in the clinic: how well do cognitive-behavioral therapies and medications work in combination?. Biol Psychiatry 2002 ; 52 : 987–997. [CrossRef] [PubMed] [Google Scholar]
  34. Storch EA, Murphy TK, Goodman WK, et al. A Preliminary study of D-cycloserine augmentation of cognitive-behavioral therapy in pediatric obsessive-compulsive disorder. Biol Psychiatry 2010 ; 68 : 1073–1076. [CrossRef] [PubMed] [Google Scholar]
  35. Nuttin B, Cosyns P, Demeulemeester H, et al. Electrical stimulation in anterior limbs of internal capsules in patients with obsessive-compulsive disorder. Lancet 1999 ; 354 : 1526. [CrossRef] [Google Scholar]
  36. Denys D, Mantione M, Figee M, et al. Deep brain stimulation of the nucleus accumbens for treatment-refractory obsessive-compulsive disorder. Arch Gen Psychiatry 2010 ; 67 : 1061–1068. [CrossRef] [PubMed] [Google Scholar]
  37. Aouizerate B, Cuny E, Martin-Guehl C, et al. Deep brain stimulation of the ventral caudate nucleus in the treatment of obsessive-compulsive disorder and major depression. Case report. J Neurosurg 2004 ; 101 : 682–686. [CrossRef] [PubMed] [Google Scholar]
  38. Mallet L, Polosan M, Jaafari N, et al. Subthalamic nucleus stimulation in severe obsessive-compulsive disorder. N Engl J Med 2008 ; 359 : 2121–2134. [CrossRef] [PubMed] [Google Scholar]
  39. Mallet L, Mesnage V, Houeto JL, et al. Compulsions, Parkinson’s disease, and stimulation. Lancet 2002 ; 360 : 1302–1304. [CrossRef] [PubMed] [Google Scholar]
  40. Mundt A, Klein J, Joel D, et al. High-frequency stimulation of the nucleus accumbens core and shell reduces quinpirole-induced compulsive checking in rats. Eur J Neurosci 2009 ; 29 : 2401–2412. [CrossRef] [PubMed] [Google Scholar]
  41. Baup N, Grabli D, Karachi C, et al. High-frequency stimulation of the anterior subthalamic nucleus reduces stereotyped behaviors in primates. J Neurosci 2008 ; 28 : 8785–8788. [CrossRef] [PubMed] [Google Scholar]
  42. Bloch MH, Landeros-Weisenberger A, Rosario MC, et al. Meta-analysis of the symptom structure of obsessive-compulsive disorder. Am J Psychiatry 2008 ; 165 : 1532–1542. [CrossRef] [PubMed] [Google Scholar]
  43. Mataix-Cols D, Rosario-Campos MCD, Leckman JF. A multidimensional model of obsessive-compulsive disorder. Am J Psychiatry 2005 ; 162 : 228–238. [CrossRef] [PubMed] [Google Scholar]
  44. Harrison BJ, Pujol J, Cardoner N, et al. Brain corticostriatal systems and the major clinical symptom dimensions of obsessive-compulsive disorder. Biol Psychiatry 2013 ; 73 : 321–328. [CrossRef] [PubMed] [Google Scholar]
  45. Aouizerate B, Martin-Guehl C, Cuny E, et al. Stimulation cérébrale profonde du striatum ventral dans le traitement du trouble obsessionnel-compulsif avec dépression majeure. Med Sci (Paris) 2005 ; 21 : 811–813. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  46. Epelbaum J., Pour les tics et tocs, serait-ce SLITRK1 ? Med Sci (Paris) 2005 ; 21 : 1117. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  47. Jupille J. Le trouble déficitaire de l’attention avec hyperactivité. Med Sci (Paris) 2011 ; 27 : 318–322. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.